Gladstone NOW: The Campaign Join Us on the Journey✕
Isha Jain, PhD, and her team developed a drug that mimics the effects of breathing low oxygen, which could be life-saving for people with mitochondrial diseases who rarely survive past childhood. In mice with Leigh Syndrome—the most common childhood mitochondrial disease—the drug extended lifespan three-fold and reversed symptoms, even when given during late stages of disease. The new drug shows the promise of gas-based therapies for mitochondrial diseases and other common brain and cardiovascular conditions for which low oxygen has been shown to be beneficial.
In this video, Jain and research associate Skyler Blume explain the science behind their discovery and the impact it could have for mitochondrial diseases. Read more about this discovery.
Featured Experts
Gladstone NOW: The Campaign
Join Us On The Journey
Could This Molecule Be ‘Checkmate’ for Coronaviruses?
Article
April 23, 2025
Could This Molecule Be ‘Checkmate’ for Coronaviruses?
Scientists develop powerful drug candidates that could head off future coronavirus pandemics.
News Release Research (Publication) COVID-19 Virology Krogan Lab Ott LabPowerful New Tool Can Identify Cells Promoting Health or Disease
Article
April 7, 2025
Powerful New Tool Can Identify Cells Promoting Health or Disease
Gladstone scientists developed a computational approach that accurately distinguishes cells of different identities or characteristics in complex biological samples used in diverse areas of biomedical and discovery research.
News Release Research (Publication) Corces LabStructure Matters: Scientists Create New Guide to Compare DNA Maps
Article
April 2, 2025
Structure Matters: Scientists Create New Guide to Compare DNA Maps
Gladstone scientists Katie Pollard and Ketrin Gjoni answer questions about their latest study, which appears in the journal Nature Methods.
News Release Research (Publication) Data Science and Biotechnology Pollard Lab Genomics Human Genetics